| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 78,113 | 68,004 | 86,773 | 90,624 | | Cost of Revenue | 72,629 | 70,788 | 66,706 | 86,414 | | | Gross Profit | 5,484 | (2,784) | 20,067 | 4,210 | | | Operating Expenses | | Research Development | 50,582 | 43,726 | 37,893 | 42,786 | | Selling General and Administrative | 87,933 | 72,284 | 47,688 | 52,059 | | Non Recurring | 1,028 | 8,254 | (2,631) | 10,674 | | Others | 405 | 404 | 404 | 884 | | | | Total Operating Expenses | 139,948 | 124,668 | 83,354 | 106,403 | | | | Operating Income or Loss | (134,464) | (127,452) | (63,287) | (102,193) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 56,881 | (28,989) | (25,613) | 13,757 | | Earnings Before Interest And Taxes | (77,583) | (156,441) | (88,900) | (88,436) | | Interest Expense | 4,546 | 4,589 | 4,778 | 5,941 | | Income Before Tax | (82,129) | (161,030) | (93,678) | (94,377) | | Income Tax Expense | (200) | 65 | (2,160) | 646 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (81,929) | (161,095) | (91,518) | (95,023) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (81,929) | (161,095) | (91,518) | (95,023) | | Preferred Stock And Other Adjustments | (3,444) | (3,372) | (13,456) | (3,004) | | | Net Income Applicable To Common Shares | ($85,373) | ($164,467) | ($104,974) | ($98,027) |
|
0.02% Nasdaq 0.00%
Income Statement
